Journal of Medicinal Chemistry · 1999 · 92 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyNucleic Acid ChemistryStructure-activity RelationshipsSynthetic Medicinal ChemistryAntiviral AgentsAntiviral PharmacologyNucleobase ChemistryRibonucleic Acid (Rna) ChemistryAntiviral Structure-activity RelationshipsNucleoside AnalogsNucleoside Analogue AntiviralsPurine AnalogsPurine ChemistryPyrimidine AnalogsPyrimidine AnaloguesPyrimidine Chemistry
A series of 4'alpha-C-branched-chain pyrimidine nucleosides was synthesized from 2'-deoxycytidine or uridine. In the 2'-deoxycytidine series, the substituent at the 4'alpha-position affected cytotoxicity against L1210 mouse leukemic cells in vitro in the order Me (23) > CN (22) > C(symbol)CH (21) > CH=CH(2) (19) > Et (24) > CH=CHCl (20). However, uridine and cytidine derivatives with ethynyl and cyano groups at the 4'alpha-position did not show any cytotoxicity. The antiviral activities of these nucleosides against HSV-1, HSV-2, and HIV-1 in vitro were also examined. Compounds 22 and 23 showed antiviral activities against HSV-1 and HSV-2 without showing significant toxicity to the host cells (MRC-5 cells). Although almost all of the nucleosides showed anti-HIV-1 activities, they were also cytotoxic to the host cells (MT-4).
20
James R. McCarthy, Donald P. Matthews, David M. Stemerick et al. · Journal of the American Chemical Society · 1991 · 195 citations
Hideshi Hattori, Motohiro Tanaka, Masakazu Fukushima et al. · Journal of Medicinal Chemistry · 1996 · 125 citations